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INTRODUCTION
Bronchial asthma is a chronic inflammatory disease of the
airway (1, 2). Chronic exposure to allergens triggers a dis-
tinct array of immunobiological and biochemical reactions
that directly stimulate and induce abnormalities of airway
structure resulting in the development of clinical symptoms
(3, 4). The airway remodeling that occurs during the initia-
tion of tissue repair in response to continuous allergic inflam-
mation in the airway consists of many different factors. These
include increase of goblet cells, hyperplasia of mucous glands,
thickening of the basement membrane due to the deposi-
tion of collagen I, III, V, fibronectin, and tenacin, alteration
of the composition of the extracellular matrix (ECM), and
hyperplasia and hypertrophy of smooth muscle fibers (5, 6).
Airway remodeling may begin at the initial stages of bron-
chial asthma, which may facilitate the continuation of tissue
damage and the inflammatory response by altering the com-
position of ECM in association with primarily eosinophils and
transforming growth factor-beta (TGF- ) released by fibro-
blasts and other growth factors. Consequently, the thickening
of the airway wall and the smooth muscle layer, and the alter-
ation of the composition of the adventitial matrix are closely
associated with the primary characteristic of asthma, airway
hyperreactivity (7, 8). Recent evidence showed that in histo-
logical examination of the airway tissues of severe or near-fatal
asthma, if subendothelial fibrosis was severe, the infiltration
of neutrophils was increased (9, 10). Since neutrophils produce
TGF- and matrix metalloproteinase (MMP)-9, they are likely
to be involved in chronic inflammation, wound repair, and
the remodeling process associated with asthma (11). However,
although airway remodeling is clinically important, the induc-
tion mechanism responsible for airway remodeling, in relation
to the airway epithelial cells, inflammatory cells, and cytokines
has not yet been elucidated. For research on airway remodel-
ing, the development of a murine model would be extremely
helpful. However, since animal models treated with ovalbu-
min have been used in most studies, there have been difficul-
ties in the evaluation of recurrence and maintenance of chron-
ic inflammation (12, 13). It was speculated that by using the
most common allergen, house dust mite (HDM), repeated
chronic exposure may induce chronic inflammation rather
than tolerance and thus airway remodeling may develop (14).
Here, in an HDM-induced bronchial asthma murine model,
we examined the airway remodeling process in response to the
chronic exposure to allergens. We analyzed the alteration of
inflammatory cells in the airway, as well as changes in inflam-
matory cells and cytokines in the bronchoalveolar lavage, and
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Inflammatory and Remodeling Events in Asthma with Chronic 
Exposure to House Dust Mites: A Murine Model 
Although animal models with ovalbumin have been used to study chronic asthma,
there are difficulties in inducing recurrence as well as in maintaining chronic inflam-
mation in this system. Using a murine model of house dust mite (HDM)-induced
bronchial asthma, we examined the airway remodeling process in response to the
chronic exposure to HDM. During the seventh and twelfth weeks of study, HDM
were inhaled through the nose for three consecutive days and airway responsive-
ness was measured. Twenty-four hours later, bronchoalveolar lavage and histo-
logical examination were performed. The degree of overproduction of mucus, subep-
ithelial fibrosis, and the thickness of the peribronchial smooth muscle in the exper-
imental group was clearly increased compared to the control group. In addition,
HDM-exposed mice demonstrated severe airway hyperreactivity to methacholine.
In the bronchoalveolar lavage fluid, the number of total cells and eosinophils was
increased; during the twelfth week, the number of neutrophils increased in the exper-
imental group. With regard to changes in cytokines, the concentrations of IL-4, IL-
13, and transforming growth factor-beta (TGF- ) were increased in the experimen-
tal group. The data suggest that eosinophils, IL-4, IL-13, and TGF- might play an
important role in the airway remodeling process and that neutrophils may be involved
with increased exposure time.
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the pattern as well as the degree of airway remodeling.
MATERIALS AND METHODS
Experimental animals
Sixty BALB/c female mice, 4-6 weeks of age, were used. Ani-
mals were raised in the animal facility at the clinical research
center of Catholic University Medical School. They were main-
tained and used according to institutional regulations devel-
oped by the institutional review board of the clinical research
center, Catholic University Medical School.
The Dermatophagoides farinae priming and immunization
The control group consisted of animals (n=30) treated with
50  L phosphate-buffered saline (PBS) inhaled through the
nose without immunization. The complete Freund’s adjuvant
group (CFA, Imject Freund’s complete adjuvant, Pierce, IL,
U.S.A.) (n=30) was sensitized with 100  g of D. farinae (Ben-
card, Worthing, U.K.) subcutaneously at the base of tail in
CFA. The CFA group was also given an intraperitoneal dose
of 300 ng of purified pertussis toxin (Sigma-Aldrich, St. Louis,
MO, U.S.A.) 24 and 72 hr after the first immunization. Seven
days later, the CFA group received again the same amount of
D. farinae in incomplete Freund’s adjuvant (Imject Freund’s
incomplete adjuvant, Pierce). Simultaneously, 25  g D. fari-
nae dissolved in 50  L PBS was administered six times; it was
inhaled through the nose once a week for 6 weeks. Seven weeks
after the immunization, the CFA 7 group (n=15) was treated
with 25  g of D. farinae by intranasal inhalation for 3 consec-
utive days and had the airway responsiveness measured, and
24 hr later, bronchoalveolar lavage and histological study were
performed. The control 7 group (n=15) was treated with PBS
only. The CFA 12 group (n=15) was treated with intranasal
inhalation of 25  g of D. farinae from 7 weeks after the immu-
nization to 11 weeks, 3 times a week. Twelve weeks after the
immunization, the CFA 12 group inhaled intranasal 25  g
of D. farinae for three consecutive days; this was followed by
measurement of airway responsiveness, and 24 hr later, bron-
choalveolar lavage and histological study were performed. The
control 12 group (n=15) was treated with PBS intranasal
inhalation of PBS instead of D. farinae (Fig. 1).
The assessment of the total serum IgE antibody response
Enzyme-linked immunosorbant assay (ELISA) detected
the total IgE level as follows: 100 microliters of anti-mouse
IgE captured mAb (clone R35-72; Pharmingen, San Diego,
CA, U.S.A.) were added to each well, plated and incubated
at 4℃, for overnight. After blocking with PBS+10% fetal
calf serum, mouse sera were incubated overnight at 4℃ and
antibody binding was assessed by the addition of 100 micro-
liters of HRP-conjugated anti-mouse IgE detection mAb (clone
R35-118; Pharmingen) overnight at 4℃. After the addition of
the enzyme substrate, plates were read at 492 nm in an ELISA
reader (Bio-Rad, Richmond, CA, U.S.A.). The purified mouse
anti-IgE antibody (Pharmigen) was used for the total IgE
standard.
Determination of D. farinae specific IgG1 antibody
response
ELISA determined D. farinae specific IgG1 as follows (15).
Fifty microliters of D. farinae (5  g/mL in 0.1 M carbonate
buffer, pH 9.6) were dispensed into each well of a polystyrene
micro titer plate (Costar, Cambridge, MA., U.S.A.) and incu-
bated overnight at 4℃. The antigen-coated plates were washed
three times with 0.05% PBS-Tween 20 buffer (washing buffer).
Then they were incubated with mice sera overnight at 4℃.
The plates were washed five times with washing buffer and
incubated with peroxidase-conjugated anti-mouse IgG1 anti-
body (Sigma, St. Louis, MO, U.S.A.) overnight at 4℃, and
then washed further five times before adding citric acid-phos-
phate buffer (pH 5.0) containing 0.15 mg/mL of O-phenylene-
diamine (Sigma). Color was developed at room temperature,
and the reaction was stopped with 2.5 M sulfuric acid, and
measured at 492 nm (Bio-Rad, Richmond, CA, U.S.A.). The
Antibody Production Units of antigen-specific antibodies were
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Fig. 1. Immunization scheme and the time course for house dust mite (HDM) sensitization and provocation. Penh, the enhanced pause value.1028 J.H. Ahn, C.H. Kim, Y.H. Kim, et al.
determined by comparison of the plot of absorbance versus dilu-
tions of the sample to that of the standard versus its concen-
tration.
Measurement of airway responsiveness
At the seventh week and twelfth week of the experiment,
each group was treated with HDM or PBS intranasal inhala-
tion. For the last treatment, the mice were placed in a baro-
metric plethysmographic chamber (OCP 2000, Allmedicus,
Anyang, Korea). Methacholine was used at the concentrations
of 3.125 mg/mL, 6.25 mg/mL, 12.5 mg/mL, and 50 mg/mL.
Three milliliters of each concentration were inhaled for 3 min
as an aerosol prepared by an Ultra-Neb (3650p, DeVilbiss,
Pennsylvania, PA, U.S.A.) and the Penh (enhanced pause) value
for 3 min was measured. The airway responsiveness was ex-
pressed as Penh, which was calculated as follows, according
to the manufacture’s protocol:
Penh=(Expiratory time/Relaxation time-1)×(Peak expi-
ration flow/Peak inspiration flow)
Results were expressed as the percentage increase in Penh
after challenge with each concentration of methacholine,
where baseline Penh (after saline challenge) is expressed as
100%. 
Analysis of bronchoalveolar lavage fluid
Twenty-four hours after the assessment of the airway res-
ponsiveness, the left major bronchus was tied with a string,
inserted with a 22-gauge needle, and the bronchoalveolar lavage
fluid was obtained by infusion and collection of 0.4 mL PBS
repeated for 3 times. The bronchoalveolar lavage fluid was cen-
trifuged at 2,000 rpm for 7 min at 4℃, and the supernatant
was stored at -70℃. The pellet was resuspended with 1 mL
PBS containing 10% FBS (Gibco, Grand Island, NY, U.S.A.),
and the total cell number was counted by mixing the 100  L
supernatant with 300  L trypan blue (Gibco, Grand Island,
NY, U.S.A.) and using a hematocytometer. The differential
calculation of alveolar macrophage, eosinophils, lymphocytes,
and neutrophils was carried out by adjusting the cell num-
ber to 1×106 cells/mL, pre- paring slides with a cytocen-
trifuge (Shandon Inc. Pittsburgh, PA, U.S.A.), staining with
Diff-Quik, and counting at least 500 cells under 400×mag-
nification.
The assessment of cytokines in the supernatant of the
bronchoalveolar lavage fluid
The concentration of IL-13, IL-4, IL-10, IFN- , and TGF-
(R&D system, Minneapolis, MN, U.S.A.) in the bron-
choalveolar lavage fluid was measured using ELISA kits.
The minimum detectable concentration was 5, 2, 4, 2, and
7 pg/mL, respectively.
Assessment of airway remodeling
The left side of the lung that did not have bronchoalveolar
lavage was resected, fixed immediately in 4% paraformalde-
hyde, and tissue sections were prepared. To examine the increase
of goblet cells in the epithelium of the bronchus, periodic acid-
Schiff (PAS) staining was performed. The degree of change was
assessed by the application of a 5-point scoring system, which
classified changes according to the proportion of goblet cells
in the epithelium of the entire bronchus. Grade 0, was the ab-
sence of goblet cells; grade 1, less than 25%; grade 2, 25-50%;
grade 3, 50-75%, and grade 4, 75-100% or the obstruction
of the bronchus by mucous (16). To examine the degree of su-
bepithelial fibrosis and the peribronchial smooth muscle layer,
Masson’s trichrome staining was performed. The stained area
of the subbasement membrane due to fibrosis and the stained
area due to smooth muscle were measured (17). For all bronchi
studied, the average value was obtained, based on the circumfer-
ence of the basement membrane, in two or three equivalent-
sized and round-shaped bronchi. All measurements were per-
formed with the computerized image analyzer program (BX50,
Olympus, Tokyo, Japan).
Statistical analysis
The data were presented as the mean±standard deviation.
The statistical analysis of parameters studied was performed
by the independent sample t-test using the software for an
IBM-PC (SPSS for Windows version 10.0). A pvalue less than
0.05 was considered statistically significant.
RESULTS
The total serum IgE and D. farinae specific IgG1 
From 3 weeks after priming, the total serum IgE response
in the CFA group (4.28±0.04  g/mL) was significantly high-
er than that in the control (p<0.01). The high levels were main-
tained until 6 weeks (5.38±0.0  g/mL), 9 weeks (6.09±
0.06  g/mL), and 12 weeks (6.11±0.06  g/mL) after induc-
tion by intranasal HDM (Fig. 2A). In regard to the D. farinae
specific IgG1 response, indirectly representative of effects of
IL-4, 3 weeks after the immunization injection, it was high-
er in the CFA group (61.86±1.68×106 APU) than in the
control group (23.26±2.10×106 APU) (p<0.01). The in-
crease lasted until 6 weeks (94.46±2.10×106APU), 9 weeks
(95.58±2.30×106 APU), and 12 weeks (117.74±1.80×
106 APU) (Fig. 2B).
Changes of inflammatory cells in the bronchoalveolar
lavage fluid
The total cell number in the broncoalveolar lavage fluidChronic Exposure to House Dust Mites 1029
of the CFA group 7 weeks after the immunization (20.24±
4.00×105/mL) and after 12 weeks (12.40±7.15×105/mL)
was significantly higher than in the control group (4.28±
0.74×105, 3.99±0.83×105/mL) (Fig. 3). The number of
eosinophils in the CFA group after 7 weeks (5.51±1.96×
105/mL) and 12 weeks (1.64±1.40×105/mL) was increased.
Similarly, in regard to neutrophils, they were higher in CFA
12 group (2.22±1.51×105/mL) than in the CFA 7 group
(0.154±0.06×105/mL) (p<0.05) (Fig. 3).
Evaluation of cytokines in the supernatant of the
bronchoalveolar lavage fluid
To examine the changes in cytokines, the presence of cyto-
kines in the supernatant of the bronchoalveolar lavage fluid was
measured. At 7 weeks after the immunization, the CFA 7 group
had higher levels than the control groups, IL-4 (33.04±10.88
pg/mL vs. 13.16±0.56), IL-13 (16.78±2.44 pg/mL vs. 8.47
±0.74), and TGF- (16.29±6.80 pg/mL vs. 4.58±0.45)
(p<0.05). Similarly, at 12 weeks, increases of IL-4 (49.70±
17.64 pg/mL vs. 13.61±0.82), IL-13 (75.20±29.22 pg/mL
vs. 7.82±0.08), and TGF- (37.68±13.88 pg/mL vs. 6.26
±1.06) (p<0.05) were detected. Among cytokines, only IL-
13 was significantly increased with increase of exposure time
(CFA 7 vs. CFA 12, p<0.05). By contrast, IL-10 and IFN-
were comparable to the control levels (Table 1).
Changes of the airway responsiveness
To assess the clinical characteristics of asthm and the pres-
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ence or absence of airway responsiveness, the bronchial provo-
cation test using methacholine was performed. It was higher
in the CFA groups than in the control groups in response to
all methacholine concentrations. There was no difference accord-
ingto the exposure time (Fig. 4).
Degree of the change of the airway remodeling
The results from the PAS staining of lung tissues showed
that there was no increase in goblet cells in the control group.
However, an increase was clearly detected in the CFA group
(Fig. 5A-C). For the Masson’s trichrome staining, an increase
in subepithelial fibrosis and thickening of the peribronchial
smooth muscle was detected in the CFA group compared to
the control 12 group (Fig. 5D-F). Measuring the increase of
goblet cells by applying the 5-point scoring system, an increase
was detected in the CFA 7 and 12 groups; however, the degree
was not changed with the exposure time. By contrast, an in-
Fig. 5. Histological analysis of lung sections at 12 weeks after systemic immunization with house dust mites. The lung sections stained with
Periodic acid-Schiff (A-C) and Masson’s trichrome (D-F). Slides were photographed at ×100 magnification. (A, D) Control 12 group, (B, E)
CFA 7 group, and (C, F) CFA 12 group. 
A B
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crease was not detected in the control group (Fig. 6A). For the
Masson’s trichrome staining, at seventh week of the experi-
ment, there was a significant increase in subepithelial fibrosis
and the thickening of the peribronchial smooth muscle layer
in the CFA 7 group compared to the controls. After 12 weeks,
the increase in the CFA 12 group continued (13.88±6.24×
104 m2 vs. 6.74±3.44×104 m2, p<0.05) (Fig. 6B). How-
ever, the change of the subepithelial fibrosis and the peribron-
chial smooth muscle areas did not change with time.
DISCUSSION
Chronic inflammation of the airway causes structural ab-
normalities and the development of airway remodeling. Among
these changes, the hyperplasia of goblet cells and structural
alterations of the subbasement membrane induce functional
impairment resulting in the appearance of the typical clinical
symptoms from bronchial hyperreactivity and airway constric-
tion (18, 19). Clinically, although early prevention or treat-
ment of airway remodeling may facilitate improvements in
asthma symptoms, specific interventions that improve airway
remodeling are scarce at present (20). Thus, in order to devel-
op the therapeutics that can treat the airway remodeling mor-
phology, characterization of the mechanism mediating airway
remodeling is required. The development of a murine airway-
remodeling model would help reach this goal. Here, we pre-
sent a murine experimental system with repeated exposure to
the common allergen, HDM, for 12 weeks, and present find-
ings of airway remodeling factors, hypertrophy of smooth mus-
cles, increase in the degree of fibrosis in mucous membranes,
and hyperplasia of goblet cells. Regarding the airway respon-
siveness and the bronchoalveolar lavage fluid, HDM-exposed
mice demonstrated that the number of eosinophils and other
allergic inflammatory reactions were enhanced and severe airway
hyperreactivity was observed in response to methacholine.
Some experiments, however, have reported that inhalation
of ovalbumin for 12 weeks weakens the degree of airway remo-
deling and observations of airway responsiveness were lost (21).
Clinically, ovalbumin is a rare allergen. It cannot induce chron-
ic airway inflammation readily by itself, and induces tolerance
rather than priming in most cases (14). In this study, allergic
bronchial asthma induced by the repeated or continuous expo-
sure to aeroallergens resulted in a chronic inflammatory con-
dition, using a common clinical allergen, HDM. This expo-
sure resulted in the maintenance of the specific characteristic
of bronchial asthma, airway remodeling.
Airway remodeling is a repair phenomenon in chronic air-
way inflammation and damage and involves various mediators.
The mechanism to maintain the normal conditions is disturbed
resulting in the appearance of hypertrophy of smooth muscles,
the fibrosis of the subbasement membrane, and hyperplasia
of goblet cells to name a few of the altered factors. In addition,
the cytokines that are involved in the immune response of the
type 2 helper cells, such as IL-13, IL-4 and TGF- , mediate
their effects on the epithelial cells in the airway. These immune
mediators result in hyperplasia of goblet cells, and simulta-
neously induce fibrosis in the subbasement membrane, caus-
Control group 7 weeks CFA group 7 weeks Control group 12 weeks CFA group 12 weeks
IL-4 (pg/mL) 13.16±0.56 33.04±10.88* 13.61±0.82 49.70±17.64*
IL-13 (pg/mL) 8.47±0.74 16.78±2.44* 7.82±0.08 75.20±29.22*
IL-10 (pg/mL) 10.51±050 10.65±0.99 10.16±0.49 16.64±8.90
IFN- (pg/mL) 4.70±0.28 4.09±0.31 4.31±0.25 4.69±0.48
TGF- (pg/mL) 4.58±0.45 16.29±6.80* 6.26±1.06 37.68±13.88*
Table 1. The level of cytokine levels in bronchoalveolar lavage fluid 
Data represent means±SD (n=15). *p<0.01 compared with asthma group.
Fig. 6. Morphometric analysis of lung histology. The ordinates indicate the score of hyperplasia of the goblet cells (A). The extent of subep-
ithelial fibrosis (B) and peribronchial smooth muscle (C) in each group. Data represent means±SE (n=15), *p<0.05 CFA group compared
with control group.
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ing alteration of the components of the extracellular matrix
(5, 6, 17, 22). The evaluation of cytokines in the bronchoalve-
olar lavage fluid performed to assess the effect of such medi-
ators showed that after 7 weeks and 12 weeks, the concen-
trations of IL-4, IL-13, and TGF- increased continuously
(Table 1). These findings are consistent with prior reports de-
monstrating that among growth factors, TGF- secreted by
the epithelial cells in the airway induces hypertrophy of smooth
muscle cells and fibrosis in the subbasement membrane by
altering myofibroblasts. In addition, the type 2 helper immune
response cytokines IL-4 and IL-13 are produced. The inter-
action between TGF- and the cytokines results in chronic
inflammation and the acceleration of airway remodeling (6).
Concerning the proportion of inflammatory cells in the
bronchoalveolar lavage fluid, in CFA 7 and 12 groups, the
total cell numbers as well as eosinophils were increased. As
the exposure to HDM continued, in the CFA 12 group, an
increase in neutrophils was detected. Simultaneous assessment
of the degree of airway remodeling showed that hyperplasia
of goblet cells, subepithelial fibrosis, and the hypertrophy of
the peribronchial smooth muscle were observed until 12
weeks, suggesting that eosinophils play an important role
in airway remodeling. 
Eosinophils released by TGF- primarily, increase the syn-
thesis of fibronectin, collagen I, and III, and thus facilitate
the progression of airway remodeling (23). The interaction
of the immune response of the Th2 helper cells and the bron-
chial epithelial cells stimulates the release of various cytokines
resulting in airway remodeling (6). Thus, it is believed that
the increase of eosinophils maintains the Th2 immune re-
sponse and simultaneously, through TGF- , facilitates the
progression, or at least the maintenance, of the airway remod-
eling.
In addition, in the airway or blood of bronchial asthma
patients, neutrophils account for over 50% of cells that are
involved in the thickening of the subbasement membrane
and cells positive for TGF- (24). Neutrophils have been
reported to play an important role in the degranulation of
goblet cells (25), which suggests an important role for neu-
trophils in airway remodeling. However, in animal studies,
from 2 hr to 48 hr after a challenge with allergens, neutrophils
have been reported to be temporarily increased in the bron-
choavleolar lavage fluid (26).
It has been reported that such a response is the result of a
challenge with a large allergen bolus in the laboratory; these
observations were not reported with chronic exposure to a
small amount of allergen where neutrophils were increased
continuously (27). In addition, it has been reported that neu-
trophils induce hyperplasia of goblet cells and the progres-
sion of subepithelial fibrosis by stimulating the airway epithe-
lial cells through the release of oxidants resulting in the release
of epidermal growth factor and TGF- , which stimulates
the infiltration of neutrophils in the airway by the release of
IL-8 (27). In our study, in the 12 week group, the number of
neutrophils in the CFA 12 group was increased even though
the number of eosinophils in the CFA-12 group was reduced
more than in the CFA 7 group. IL-13 was increased in the
supernatant of the bronchoalveolar lavage fluid, and the high
level of IL-4 and TGF- was maintained. This suggests the
involvement of neutrophils in airway remodeling with in-
creased exposure time. 
It was observed that the total serum IgE antibody response
induced by the type two helper cell responses was increased
in the CFA group until 6 weeks and continued for 12 weeks,
and the D. farinae specific IgG1 antibody response, which is
influenced by IL-4, increased with the increase of the exposure
time to allergens.
IFA is a surfactant composed of paraffin oil containing
mannide mono-oleate. It has been reported that CFA is a
potent adjuvant as it contains heat-inactivated mycobacte-
ria, lengthens the period of the presence of allergens when
administered together, and delivers them efficiently to the
immune system. IFA induces the type 2 helper cell response
and thus increases antibody production (28). Here, our data
demonstrate that the application of such an adjuvant together
with HDM allows maintenance of the type 2 helper response
continuously. 
In conclusion, our data demonstrate that repeated exposure
to HDM maintains continuously airway-remodeling factors,
hypertrophy of smooth muscles, increase of fibrosis in the sub-
basement membrane, hyperplasia of goblet cells, and the aller-
gic inflammatory response such as airway hyperreactivity. In
addition, in the bronchoalveolar lavage fluid, the increase of
IL-4, IL-13, and TGF- was maintained, and this may play
an important role in the airway remodeling process. In addi-
tion, neutrophils increased as the exposure time increased,
which suggests that neutrophils may also play an important
role in the etiology of chronic bronchial asthma. 
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